Fernando C Baltanás

7PUBLICATIONS
17CO-AUTHORS
Molecular targetsCancer diagnosisHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 12, 2025
SOS1 inhibitor BI-3406 shows in vivo antitumor activity akin to genetic ablation and synergizes with a KRASG12D inhibitor in KRAS LUAD.

Fernando C Baltanás, Maximilian Kramer-Drauberg, Rósula García-Navas

|Sep 20, 2023
Critical requirement of SOS1 for tumor development and microenvironment modulation in KRASG12D-driven lung adenocarcinoma.

Fernando C Baltanás, Rósula García-Navas, Pablo Rodríguez-Ramos

|Apr 28, 2023
Advances in Molecular Research of Oncogenes.

Fernando C Baltanas, Eugenio Santos

|Aug 26, 2022
Critical Requirement of SOS1 for Development of BCR/ABL-Driven Chronic Myelogenous Leukemia.

Carmela Gómez, Rósula Garcia-Navas, Fernando C Baltanás

|Jul 02, 2021
SOS2 Comes to the Fore: Differential Functionalities in Physiology and Pathology.

Fernando C Baltanás, Rósula García-Navas, Eugenio Santos

Pageof 2